VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,748 | -50.9% | 306,488 | -33.4% | 0.00% | – |
| Q2 2023 | $648,932 | -8.9% | 460,235 | +2.8% | 0.00% | – |
| Q1 2023 | $712,004 | +8.8% | 447,801 | -0.1% | 0.00% | – |
| Q4 2022 | $654,190 | -76.9% | 448,075 | -32.4% | 0.00% | – |
| Q3 2022 | $2,830,000 | +34.5% | 662,600 | +22.2% | 0.00% | – |
| Q2 2022 | $2,104,000 | -80.9% | 542,431 | -76.5% | 0.00% | – |
| Q1 2022 | $11,010,000 | +27.3% | 2,312,908 | -2.4% | 0.00% | – |
| Q4 2021 | $8,646,000 | -48.3% | 2,368,918 | +13.6% | 0.00% | – |
| Q3 2021 | $16,723,000 | -28.5% | 2,085,048 | +1.2% | 0.00% | -100.0% |
| Q2 2021 | $23,375,000 | +1256.6% | 2,061,171 | +1006.2% | 0.00% | – |
| Q1 2021 | $1,723,000 | – | 186,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,120,000 | 0.80% |
| Samsara BioCapital, LLC | 689,709 | $2,676,000 | 0.71% |
| BVF INC/IL | 3,614,662 | $14,025,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $277,000 | 0.11% |
| MAI Capital Management | 647,950 | $2,514,000 | 0.05% |
| Laurion Capital Management LP | 698,000 | $2,708,000 | 0.04% |
| Jasper Ridge Partners, L.P. | 92,939 | $361,000 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $80,000 | 0.02% |
| Ergoteles LLC | 155,562 | $604,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 25,000 | $97,000 | 0.01% |